(Q47392500)

15 January 2018

title

Determinants of Prostate Cancer Specific Survival Following Radiation Therapy During the Prostate Specific Antigen Era (English)

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000094800.63501.15

31 March 2024

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000094800.63501.15

31 March 2024

author name string

Kerri Cote

2

1 reference

15 January 2018

Marian Loffredo

3

1 reference

15 January 2018

Delray Schultz

5

1 reference

15 January 2018

Anthony V. D'Amico

1

1 reference

PubMed ID

14610409

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14610409

31 March 2024

Andrew A. Renshaw

4

1 reference

PubMed ID

14610409

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14610409

31 March 2024

language of work or name

English

0 references

publication date

1 December 2003

1 reference

15 January 2018

full work available at URL

http://api.elsevier.com/content/article/PII:S0022534701682557?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000094800.63501.15

http://api.elsevier.com/content/article/PII:S0022534701682557?httpAccept=text/plain

31 March 2024

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000094800.63501.15

http://www.jurology.com/doi/pdf/10.1097/01.ju.0000094800.63501.15

31 March 2024

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000094800.63501.15

31 March 2024

1 reference

15 January 2018

volume

170

1 reference

15 January 2018

page(s)

S42-6; discussion S46-7

1 reference

15 January 2018

issue

6 Pt 2

1 reference

15 January 2018

Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer

cites work

1

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000094800.63501.15

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis

31 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000094800.63501.15

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

31 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000094800.63501.15

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.

31 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000094800.63501.15

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

31 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000094800.63501.15

Natural history of progression after PSA elevation following radical prostatectomy

31 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000094800.63501.15

Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations

31 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000094800.63501.15

Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial

31 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000094800.63501.15

Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel

31 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000094800.63501.15

Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy

31 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000094800.63501.15

Nonparametric Estimation from Incomplete Observations

31 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000094800.63501.15

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

31 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000094800.63501.15

Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen

31 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000094800.63501.15

PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer

31 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000094800.63501.15

Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy

31 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000094800.63501.15

Surrogate endpoints in clinical trials: definition and operational criteria

31 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/01.JU.0000094800.63501.15

31 March 2024

Identifiers

1 reference

15 January 2018

PubMed ID

14610409

1 reference

15 January 2018